Cadila gets USFDA nod for generic drug to treat Parkinson Ruby Khatun Khatun15 Dec 2017 4:08 PM ISTNew Delhi: Cadila Healthcare said it has received approval from the US health regulator to market Pramipexole Dihydrochloride extended-release...
Lupin gets USFDA nod for generic contraceptive tablets Ruby Khatun Khatun15 Dec 2017 10:30 AM ISTNew Delhi: Drug major Lupin said it has received approval from the US health regulator to market its Tydemy tablets, used to prevent pregnancy, in the...
Glenmark completes phase 3 study for nasal spray Ruby Khatun Khatun15 Dec 2017 10:15 AM ISTNew Delhi: Glenmark Pharmaceuticals said it has completed phase 3 study of its investigational fixed-dose combination nasal spray and plans to submit...
FDA approves first drug for Eosinophilic Granulomatosis with Polyangiitis Ruby Khatun Khatun15 Dec 2017 10:06 AM ISTThe U.S. Food and Drug Administration (FDA) expanded the approved use of Nucala (mepolizumab) to treat adult patients with eosinophilic granulomatosis...
USFDA accepts application for Indivior's new schizophrenia drug Ruby Khatun Khatun15 Dec 2017 9:45 AM ISTU.S. Food and Drug Administration (FDA) accepted Indivior's application for its new schizophrenia treatment, the British drugmaker said on Tuesday,...
Did Sanofi, WHO ignore warning signals on dengue vaccine? Ruby Khatun Khatun15 Dec 2017 9:30 AM ISTCHICAGO/LONDON: When French drugmaker Sanofi published the results of clinical trials of children given its dengue vaccine two years ago, the overall...
Cipla launches 2 digital education platforms-Ciplamed and Breathefree Ruby Khatun Khatun14 Dec 2017 11:00 AM ISTMumbai: In continuation to its commitment to patient-centricity and digitization, Cipla announces the launch of two digital assets, one aimed at...
JB Chemicals and Pharma gets USFDA nod for hypertension tablets Ruby Khatun Khatun14 Dec 2017 10:30 AM ISTNew Delhi: JB Chemicals & Pharmaceuticals has received US health regulator's nod for Atenolol tablets, used in the treatment of high blood...
IMA urges Govt to come out with ordinance reg drug prices Ruby Khatun Khatun14 Dec 2017 10:16 AM ISTNew Delhi: The Indian Medical Association (IMA) on Monday urged the Government to come out with an urgent ordinance for one drug-one company-one price...
Merck raises stakes in lung cancer as rivals close in Ruby Khatun Khatun14 Dec 2017 10:01 AM ISTLOS ANGELES: Merck & Co Inc, maker of the only immunotherapy approved for patients newly-diagnosed with the most common type of lung cancer, could...
GSK's new pharma head on lookout for cancer deals to boost pipeline Ruby Khatun Khatun14 Dec 2017 9:45 AM ISTLONDON: GlaxoSmithKline (GSK) will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its...
Sanofi investors hungry for drug progress and deal news Ruby Khatun Khatun14 Dec 2017 9:30 AM ISTPARIS: Sanofi still needs to convince markets it can deliver on an exciting and sustainable growth path as it contends with fresh difficulties in its...
